retatrutide glp-1 medication Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Understanding the Next-Gen Weight Loss

Many patients struggle with appetite, cravings, insulin resistance, slow metabolism, hormonal changes, stress, poor sleep, and medical conditions that make weight loss more difficult

Big perks can come from small doses

FDA Compounding Policies Impacting Tirzepatide in 2026 The FDA has made its rules on drug compounding clear, with more focus on GLP-1 rules now that there is enough supply

Some studies warn of pitfalls that can occur when trying to transition away from using the expensive medications, including the regaining of weight, NPR reported

Which is true

But once the poison gets in your system, Bunyard said, it targets your liver and other organs, recirculating through your bloodstream and essentially re-dosing you with the toxin